Revenue | ₹7,975.36Cr |
Net Profits | ₹824.75Cr |
Net Profit Margins | 10.34% |
Aurobindo Pharma Ltd’s revenue jumped 2.41% since last year same period to ₹7,975.36Cr in the Q1 2025-2026. On a quarterly growth basis, Aurobindo Pharma Ltd has generated -6.36% fall in its revenue since last 3-months.
Aurobindo Pharma Ltd’s net profit fell -10.28% since last year same period to ₹824.75Cr in the Q1 2025-2026. On a quarterly growth basis, Aurobindo Pharma Ltd has generated -8.71% fall in its net profits since last 3-months.
Aurobindo Pharma Ltd’s net profit margin fell -12.39% since last year same period to 10.34% in the Q1 2025-2026. On a quarterly growth basis, Aurobindo Pharma Ltd has generated -2.51% fall in its net profit margins since last 3-months.
The revenue for Aurobindo Pharma Ltd in the Q1 results 2025 was ₹7,975.36Cr.
The net profit for Aurobindo Pharma Ltd in the Q1 results 2025 was ₹824.75Cr.
The net profit margin for Aurobindo Pharma Ltd in the Q1 results 2025 was 10.34%.
The revenue for Aurobindo Pharma Ltd in the Q1 results 2024 was ₹7,787.95Cr.
The net profit for Aurobindo Pharma Ltd in the Q1 results 2024 was ₹919.22Cr.
The net profit margin for Aurobindo Pharma Ltd in the Q1 results 2024 was 11.80%.